Navigation Links
Symposium will include venture capital "coaching"

Madison, Wis. - What do venture coaching, the "Elevator Pitch Olympics," and venture readiness workshops have in common?

All will be components of the second annual Wisconsin Early Stage Symposium, which will be held on Monday and Tuesday, Oct. 30 and 31, at Monona Terrace Convention Center. The symposium is co-produced by the
Full article >>> sity of Wisconsin-Madison's Wisconsin Institutes for Discovery project.

An address by Dr. Thomas "Rock" Mackie, a co-founder of TomoTherapy, Inc., a Wisconsin biotechnology success story in the field of medical technology.

For more information, call 608-442-7557 or visit the Wisconsin Technology Council's website. More info......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/25/06


Related biology technology :

1. Early Stage Symposium session will help emerging companies prepare for investors
2. Milwaukee to host inaugural Great Lakes Agro-Security Symposium
3. Symposium examines the effect of race on genetics and disease
4. Belmont Report Commission reuniting for Medical College of Wisconsin Symposium
5. Symposium To Explore Information Technologys Impact on Improving Quality, Cost Effectiveness of Healthcare
6. Medical Technologies and Devices Symposium
7. Michigan Growth Capital Symposium includes Wisconsin Tech Companies
8. DHC 2007: Barriers to electronic data exchange include the law
9. Healthcare of business: Universal coverage plan includes new business taxes
10. Grow Milwaukee includes millions for tech funding
11. Computerworld top 100 includes three Wisconsin CIOs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
(Date:2/16/2017)... DIEGO , Feb. 16, 2017  Dermata ... innovative products to treat a variety of dermatological ... million Series 1a financing and entered into a ... (SVB).  Dermata intends to use the capital for ... making major advancements in the treatment of serious ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 Ipsidy ... Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a ... transaction processing services, is pleased to announce the following ... Effective January 31, 2017, Philip D. ... Directors, CEO and President.  An experienced payment industry professional ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
Breaking Biology News(10 mins):